| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |